Johnson & Johnson Total Change in Assets/Liabilities 2010-2025 | JNJ
Johnson & Johnson annual/quarterly total change in assets/liabilities history and growth rate from 2010 to 2025. Total change in assets/liabilities can be defined as the sum of all line items in the Asset/Liability section of the Cash Flows Statement
- Johnson & Johnson total change in assets/liabilities for the quarter ending March 31, 2025 was $-11.028B, a 3162.72% increase year-over-year.
- Johnson & Johnson total change in assets/liabilities for the twelve months ending March 31, 2025 was $-8.942B, a 792.64% decline year-over-year.
- Johnson & Johnson annual total change in assets/liabilities for 2024 was $1.848B, a 26.29% decline from 2023.
- Johnson & Johnson annual total change in assets/liabilities for 2023 was $2.507B, a 162.24% decline from 2022.
- Johnson & Johnson annual total change in assets/liabilities for 2022 was $-4.028B, a 6.02% decline from 2021.
Johnson & Johnson Annual Total Change in Assets/Liabilities
(Millions of US $) |
| 2024 |
$1,848 |
| 2023 |
$2,507 |
| 2022 |
$-4,028 |
| 2021 |
$-4,286 |
| 2020 |
$2,753 |
| 2019 |
$3,845 |
| 2018 |
$-28 |
| 2017 |
$11,258 |
| 2016 |
$-1,784 |
| 2015 |
$1,647 |
| 2014 |
$-855 |
| 2013 |
$-959 |
| 2012 |
$-969 |
| 2011 |
$1,523 |
| 2010 |
$-858 |
| 2009 |
$1,339 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$352.153B |
$88.821B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
